An affordable price is probably the major benefit persuading people to buy drugs at www.americanbestpills.com. The cost of medications in Canadian drugstores is considerably lower than anywhere else simply because the medications here are oriented on international customers. In many cases, you will be able to cut your costs to a great extent and probably even save up a big fortune on your prescription drugs. What's more, pharmacies of Canada offer free-of-charge shipping, which is a convenient addition to all other benefits on offer. Cheap price is especially appealing to those users who are tight on a budget
Service Quality and Reputation Although some believe that buying online is buying a pig in the poke, it is not. Canadian online pharmacies are excellent sources of information and are open for discussions. There one can read tons of users' feedback, where they share their experience of using a particular pharmacy, say what they like or do not like about the drugs and/or service. Reputable online pharmacy canadianrxon.com take this feedback into consideration and rely on it as a kind of expert advice, which helps them constantly improve they service and ensure that their clients buy safe and effective drugs. Last, but not least is their striving to attract professional doctors. As a result, users can directly contact a qualified doctor and ask whatever questions they have about a particular drug. Most likely, a doctor will ask several questions about the condition, for which the drug is going to be used. Based on this information, he or she will advise to use or not to use this medication.

Meet Doug Letter, Pelosi’s go to Lawyer

In litigation against President Trump, look no further than Douglas Letter hired almost two years ago by Speaker Pelosi. Whether it is the House seeking access to Donald Trump’s private tax records, coordinating impeachment operations, filing amicus briefs, border wall litigation, benefits to illegal aliens and getting legal citizenship or most of all gaining the redacted Mueller investigation documents, Letter has been involved in an estimated 31 case actions at the behest and approval of Nancy Pelosi.

   photo

Doug Letter was hired in December of 2018 and came with a resume that included serving as the Director of the Civil Division Appellate Staff at the Department of Justice where he spent 40 years. He is a senior litigator at the Institute for Constitutional Advocacy and Protection at Georgetown University Law Center. After graduating from of Berkeley Law School, he joined the DoJ and argued more than 200 cases before the Supreme Court. Additionally, he was the White House Associate Counsel to President Clinton, the Deputy Associate Attorney under Janet Reno and Senior Counsel to Eric Holder.

Meanwhile, the House Republicans have hired Charles (Chuck) Cooper. At least 20 House Republicans are suing Nancy Pelosi on the matter of proxy voting. It should be noted that the proxy vote on the issue of re-upping the FISA legislation was pulled late in the day allegedly because President Trump said he would veto the bill. Gotta wonder if it was really due to the lawsuit.

Chuck Cooper, the Other Lawyer in Gay-Marriage Case - WSJ photo

Charles Cooper and and Doug Letter for sure know each other from their time at the Department of Justice. Cooper represented big names such as Jeff Sessions during the recusal on Russian interference. Then there was John Ashcroft and John Bolton where it was slated that he was possibly scheduled to testify during the impeachment inquiry.

Cooper began working too in the Civil Rights Division at the DoJ in 1981 as was appointed Assistant Attorney General at the Office of Legal Counsel during the Reagan administration. Cooper’s law firm in private practice of Cooper and Carvin had legal alumni such as Senator(s) Tom Cotton and Ted Cruz along with Victor Wolski a Federal judge and Solictor General Noel Francisco. Cooper has argued 7 cases before the Supreme Court and previously clerked for Justice William Renquist.

The House Republicans lawsuit is found here.

House Democrats installed the new rules on proxy voting on a largely party line vote of 217 to 189. Republican argued that the move bucks the chamber’s institutional history and sets a dangerous precedent.

On Wednesday, the House Rules Committee is slated to hold the chamber’s first remote hearing under the new rules. Each panel must hold a practice hearing, followed by two virtual sessions. Once those steps are completed, a panel can hold a markup by video conference as well.

The House Ways and Means Committee is also slated to hold its first remote hearing later Wednesday.

At this time, the panels can use Cisco Webex to hold the virtual hearings.

For much of the past two months, the chamber’s regular business largely came to a halt, and has since only held a handful of votes related to coronavirus legislation. The chamber’s meeting of what is now 431 members and additional support staff have proved particularly problematic amid the coronavirus pandemic.

Sanction China by Stopping World Bank Loans to CCP

Decoupling the United States from China is a convoluted and complicated process. Some lawmakers make it sound easy by just terminating manufacturing agreements by U.S. companies and bring it stateside. Ah but hold on…it is important to know some other details that lawmakers on both sides of the aisle are not telling you.

Consider the items below:

1.  Commerce Department official warned Congress recently that China is raising billions of dollars in U.S. capital markets and the activity could undermine American security.

Nazak Nikakhtar, assistant secretary for international trade at the Commerce Department, testified last month that Chinese companies raised $48 billion from American capital markets from 2013 through the end of last year.

Ms. Nikakhtar told the congressional U.S.-China Economic and Security Review Commission that 172 Chinese companies in September were listed on the three largest U.S. exchanges — Nasdaq, the New York Stock Exchange and the NYSE American — with a total market capitalization of more than $1 trillion. More here.

Confucius Institutes and U.S. Exchange Programs: Public ...

2. Charles Lieber, the chair of Harvard University’s Department of Chemistry and Chemical Biology, and two Chinese nationals who were researchers at Boston University and a Boston hospital were charged by the U.S. Justice Department with lying about their purported links to the Chinese government. But hold on, it is much worse. China has a real impact on all levels of the U.S. education system. The Senate Permanent Subcommittee on Investigations issued a 96 page report describing the Confucius Institute and how those agreements work with domestic universities. Further, major universities failed to report the other monies they receive from China among other countries. It is shocking how foreign money has infiltrated the U.S. education system and to learn which country does what and how much, click here.

China moon landing: Spacecraft makes first landing on moon ...

3. China launched its Long March 5B rocket into space. This is an effort by China to build a modular space station. It did however fall out of orbit falling for the most part into the Atlantic Ocean off the coast of Africa near the Ivory Coast. Additionally, as China continues to launch at least 12 more space operations it already has landed on the dark side of the moon. China and Russia are in fact collaborating on lunar operations including for shared bases. Russia’s operations coordinating with China are centered and funded by Roscosmos for Space Activities and the Skulkovo Foundation. This is the foundation where Hillary Clinton created U.S. technology (Silicon Valley) and Skulkovo via the Clinton Foundation via a major donor known as Viktor Vekselberg. This is the other scandal of technology transfer(s) to rogue nations.

4. We are already somewhat versed in Chinese complicity in the pandemic and the World Health Organization but lets go to the World Bank shall we? As of early 2019, China was sitting on cash reserves of some $3 trillion. It is the world’s second-largest economy, behind the U.S. It directly lends more money to other nations each year than the $2 billion or so it borrows from the World Bank annually. The World Bank, based in Washington, D.C., was established after World War II to help European countries rebuild. Its mission has evolved over the years and is now to finance development in low- and middle-income countries with the goal of eliminating extreme poverty.

“From a pure economic vantage point, there is no good reason for the World Bank to continue making loans to China,” says Eswar Prasad, a professor of economics at Cornell University.

“The Chinese don’t need the money,” Prasad says. “There is a glaring optics problem.” He adds that the argument could be made that the money lent to China could be put to better use elsewhere.

And it’s not as if the World Bank has an infinite amount of money to parcel out. Its lending budget, drawn from reserves, donations and the interest it earns on capital, is limited. So a dollar lent to China is a dollar that is not available for a project somewhere else in the world. The Trump administration, which regularly beats up on China, accusing it of manipulating global trade rules for its own benefit, has blasted the World Bank for lending too much to China.

Prasad says the World Bank’s lending to China is becoming “untenable” and will have to stop fairly soon.

Bert Hofman, the World Bank’s country director for China, says the amount of money China is borrowing each year from the global bank is just a small fraction of what the country is investing each year in domestic programs. And he believes that a motivation for China’s borrowing goes beyond money.

“The reason they still borrow is because they feel that the expertise of the World Bank is valuable to them,” Hofman says.

World Bank loans come with advisers and auditors who help implement (and monitor) bank-funded projects.

China gets access to international experts. The World Bank remains engaged with China and is able to see how new projects play out in this booming middle-income country. Hofman sees it as a win-win.

Prasad agrees that there are still some good reasons for the World Bank to remain engaged with China. Many of the bank’s loans to China are for projects addressing climate change and mitigating pollution from the country’s booming factories.

“The risk the World Bank faces is that if it only lends to very poor countries, it might end up not having much of a role to play in the large, fast-growing emerging-market economies,” Prasad says. “So the World Bank, in a bid to remain relevant and push its agenda on issues such as climate change and social development, has continued to lend to China.” More here.

***

The World Bank said its board adopted a new plan to aid China with $1 billion to $1.5 billion in low-interest loans annually through June 2025, despite the objections of U.S. Treasury Secretary Steven Mnuchin and several U.S. lawmakers.

World Bank approves $300mn for agriculture reforms in ...

Mnuchin told a House Financial Services Committee hearing that the Treasury’s representative on the board had objected on to the plan on Wednesday, adding he wants the World Bank to “graduate” China from its concessional loan programs for low- and middle-income countries.

The five-year lending strategy plan was published on Thursday afternoon after the World Bank’s board “expressed broad support” for the multilateral development lender’s engagement in China’s structural and environmental reforms.

The World Bank said its lending would decline over the “country partnership framework” plan, in line with reformsagreed under a $13 billion capital increase agreed in 2018.

The World Bank loaned China $1.3 billion in the fiscal 2019 year ended June 30, down from about $2.4 billion during fiscal 2017. The new plan calls for lending to “gradually decline” from the previous five-year average of $1.8 billion.

“Lending levels may fluctuate up and down from year to year due to normal pipeline management based on project readiness,” the World Bank said in its plan.

*** So we have a collection of reparation options due to the pandemic when it comes to China, we have a building space battlefield, we have corruption within China and now we have the U.S. at major odds with the Chinese Communist Party’s in violation of the One Country, Two Systems Act of 1997 with regard to Hong Kong. Secretary of State Pompeo declared to Congress that Hong Kong was no longer autonomous with The CCP which is correct but this will spark continued hostilities between the two nations even as naval conflicts continue in the South China Sea.

None of this will be easy but the reader should know more details to assess what may be ahead in global relations.

 

Legislation to Regain US Control of Critical Minerals from China

WASHINGTON, D.C. – U.S. Sen. Ted Cruz (R-Texas), member of the Senate Foreign Relations Committee, today introduced the Onshoring Rare Earths Act of 2020 or ORE Act, legislation to end U.S. dependence on China for rare earth elements and other critical minerals used to manufacture our defense technologies and high tech products by establishing a supply chain for these minerals in the U.S., including by requiring the U.S. Department of Defense (DOD) to source these minerals domestically.

Upon introducing the legislation, Sen. Cruz said:

“Our ability as a nation to manufacture defense technologies and support our military is dangerously dependent on our ability to access rare earth elements and critical minerals mined, refined, and manufactured almost exclusively in China. Much like the Chinese Communist Party has threatened to cut off the U.S. from life-saving medicines made in China, the Chinese Communist Party could also cut off our access to these materials, significantly threatening U.S. national security. The ORE Act will help ensure China never has that opportunity by establishing a rare earth elements and critical minerals supply chain in the U.S.”

*** Rare earth mineral deal inked by US and Australia — what ... photo

Noted by Forbes:

A whole slate of new bad behaviors by China’s repressive regime have been laid bare by the COVID-19 crisis. There were already plenty of complaints before the pandemic began, but the coronavirus seems to be supercharging the pressure on U.S. companies to reduce their Chinese sourcing. One of the biggest recent challenges in that regard has been China’s dominance in mining and processing critical rare earth minerals. These are vital building blocks for everything from smart phones, EV batteries and medical imaging machines to advanced defense weaponry, so our reliance on a less-than-friendly nation for our supply presents a huge political and economic risk. But right now China controls 90% of global rare earth production.

It’s amazing good fortune, then, that out in the barren scrub of Far West Texas 85 miles east of El Paso, an unassuming 1,250-tall mountain called Round Top holds the promise of making America largely self-sufficient in these critical minerals. The mountain contains five out of six light rare earths (such as neodymium), 10 out of 11 heavy rare earths (dysprosium, for example), and all five permanent magnet materials. What’s more, Round Top has large deposits of lithium, critical for batteries in EVs and power storage. More here.

See the U.S map here.

The global map is here.

According to the United States Geological Survey, as of 2018, China produced around 80% of world demand for rare earth metals (down from 95% in 2010). Their ores are rich in yttrium, lanthanum, and neodymium.

Since August of 2010, fears over Chinese dominance of crucial rare earth supplies have lingered as China restricted export quotas of the metals with no official explanation, immediately sparking debate over decentralization of world rare earth production.

Rare earth element mines, deposits, and occurrences photo

Great quantities of rare earth ores were found in California in 1949, and more are being sought throughout North America, but current mining is not significant enough to strategically control any portion of the global rare earths market (the Mountain Pass mine in California still has to ship its minerals to China to be processed).

Rare earths are traded on the NYSE in the form of exchange-traded funds (ETFs) that represent a basket of supplier and mining stocks, as opposed to trading in the metals themselves. This is due to their rarity and price, as well as their almost strictly industrial consumption. Rare earth metals are not considered a good physical investment like precious metals, which hold low-tech intrinsic value.

*** How did this happen?

In part:

Economically, the biggest changes happened in the 1990s and early 2000s, starting when the United States conferred permanent “Most Favored Nation” status on China.

These decisions proved disastrous.

“Prior to that, we could only give China [Most Favored Nation status] one year at a time because we had a law that said you can’t give a communist country permanent [Most Favored Nation] trade treatment,” said Mulloy. “Each year, if China wasn’t behaving properly, we could take it away.”

“It was a terrible mistake to give it up because we were unable to manage or govern the Chinese after that,” agreed Halper.

The next shoe to drop came with China’s inclusion in the World Trade Organization.

The U.S. only approved China’s entry on the condition that we could continue to punish what we considered unfair trade practices by China or anyone else. But when that position was challenged within the World Trade Organization, we agreed not to penalize anyone unless we won a dispute at the World Trade Organization.

We handcuffed ourselves and we’ve been handcuffed ever since. What was once an $80 billion trade deficit is now at $4.5 trillion. It should have been foreseeable, but Wall Street and multinational corporations, which foresaw big returns from China, lobbied Congress hard to get these things approved.

 

Trump Halts Federal Retirement Accounts Investing in China

In February of 2020, this site published an article describing the California Public Pension Fund’s investment in Chinese stocks could lead to national security risks and even spying. The value of the fund is $3.1 Billion. Meanwhile, Speaker Pelosi refuses to approve House committee hearings on anything related to China….

The Chinese Communist Party has both different accounting rules for corporations reporting financial data and or refuses to release any accounting data. How and why Chinese companies are listed on U.S. Stock Exchanges in the first place is an unanswered question and one that is likely being reviewed now by the Securities and Exchange Commission along with several other agencies due to a very contested relationship between the U.S. and China due to the virus outbreak.

Please find linked a complete list of all Chinese companies listed on the NASDAQ, New York Stock Exchange, and NYSE American, the three largest U.S. exchanges. As of February 25, 2019, there were 156 Chinese companies listed on these U.S. exchanges with a total market capitalization of $1.2 trillion.

An asterisk next to the stock symbol indicates a company with at least 30 percent state ownership. As of February 25, 2019, there were at least 11 Chinese state-owned companies listed on the three major U.S. exchanges.

A highlighted row indicates a company that was not included on the Public Company Accounting Oversight Board’s (PCAOB) September 2018 review of non-U.S. companies where the PCAOB is denied access to conduct inspections.

So as an interesting measure to begin measures against China, President Trump issued a letter to the Labor Secretary to halt investments in Federal Savings Plans in Chinese equities.

 

 

 

 

 

 

 

 

 

 

A second letter was sent by the Secretary of Labor to the Thrift Investment Board and that is found here.

Rather than the normal contested and really stupid questions that the media asks during White House daily briefings, there are some real questions that should be asked and they include all things China.

For some context on how China is all over the United States, consider the information below.

For many Chinese companies, their dreams of listing in New York are only on hold.

Some high-profile Chinese stocks listed in the U.S. such as Luckin Coffee, the self-proclaimed Starbucks rival in China, have been rocked following allegations by short-sellers that these companies faked their numbers, accusations that in some cases are now being internally investigated.

The reports are the latest challenge for Chinese initial public offerings in New York, on top of U.S.-China trade tensions and the impact of the coronavirus.

But some in the cross-border IPO business say the listing plans are just delayed, not canceled.

“I do know Chinese companies that are planning to list this summer as soon as after Labor Day,” said Jim Fields, a Shenzhen-based producer of videos for Chinese companies presenting to potential IPO investors in the U.S. China celebrates the holiday on May 1.

Fields noted the new IPO timeframe is a delay of about one to three months.

Last year, 25 Chinese issuers went public in the U.S., in addition to three special-purpose acquisition companies — companies that raise money to buy another — according to Renaissance Capital, which sells IPO-focused exchange-traded funds. That’s down from 32 Chinese listings in 2018, which was double that of the prior year and the most since 2010.

Despite geopolitical and epidemiological challenges in the first three months of this year, seven Chinese companies and three special-purpose acquisition companies went public in the U.S., according to Matthew Kennedy, IPO market strategist at Renaissance Capital.

“We suspect several more had planned to list, but delayed their offerings amid the Covid-19 outbreak,” Kennedy said in an email. “As we noted in our 1Q20 Review, China appears to be the first country emerging from the pandemic, so Chinese companies may also be first to return to the IPO market. However, these financial scandals do reputational damage to Chinese issuers broadly.”

On April 2, Luckin Coffee announced an internal investigation found the chief operating officer fabricated sales by about 2.2 billion yuan ($314 million) from the second to fourth quarter of last year. Shares have plunged more than 80% since the latest disclosure this month, and have been halted for pending news for roughly the last week.

About two months ago, investment firm Muddy Waters said it was shorting, or betting on a decline in the price of the stock, based on an anonymous report that alleged the coffee company fabricated financial and operating numbers beginning in the third quarter of last year. Luckin said at the time the allegations were “misleading and false.”

The company did not respond to a request for comment. Representatives from Nasdaq and the New York Stock Exchange were not available for interviews for this story.

Other high-profile U.S.-listed stocks have come under scrutiny in the last several days.

Shares of video streaming site iQiyi, which is majority-owned by search giant Baidu, dipped last week after a report by Wolfpack Research alleged the video company inflated revenue by about $1 billion to $2 billion. Muddy Waters said it assisted Wolfpack with the report and is also betting against iQiyi’s stock. The Chinese company said in a statement it believed the report contained “errors” and was “misleading.”

China's hottest companies - Tal Education (8) - CNNMoney

Tutoring company TAL Education announced last week it suspected an employee of inflating sales for its “Light Class” product, which accounts for about 3% or 4% of the company’s total estimated revenues. TAL said the employee has been taken into custody by the local police. More here.

Operation Warp Speed

The mission is for the United States to have the ability to inoculate 300m people by January 2021. In collaboration between Health and Human Services, the FDA and the Department of Defense, the DOD has a unique division known as The Research Regulatory Oversight Office (R2O2) which is the P&R component level oversight office for the authorities and responsibilities under Department of Defense (DoD) Instruction 3216.01, “Use of Animals in DoD Programs.” The R2O2 manages animal care and use review and oversight processes for research conducted and supported by the Uniformed Services University of the Health Sciences and the Armed Forces Radiobiology Research Institute, both of which are accredited by AAALAC as is required for all DoD institutions housing animals for Research, Development, Testing and Evaluation or training.

U.S. Department of Defense and FDA collaborate to help speed ... source

***

The Trump administration is organizing a Manhattan Project-style effort to drastically cut the time needed to develop a coronavirus vaccine, with a goal of making enough doses for most Americans by year’s end.

Called “Operation Warp Speed,” the program will pull together private pharmaceutical companies, government agencies and the military to try to cut the development time for a vaccine by as much as eight months, according to two people familiar with the matter.

As part of the arrangement, taxpayers will shoulder much of the financial risk that vaccine candidates may fail, instead of drug companies.

The project’s goal is to have 300 million doses of vaccine available by January, according to one administration official. There is no precedent for such rapid development of a vaccine.
Last month, Trump directed Health and Human Services Secretary Alex Azar to speed development of a vaccine, and administration officials have been meeting on the effort for three to four weeks, one of the people said. A meeting on the project was scheduled at the White House on Wednesday.

The people familiar with the project and the administration officials asked not to be identified because it hasn’t yet been publicly announced.

A spokesman for the Department of Health and Human Services, Michael Caputo, said the president refused to accept the timeline for standard vaccine development and encouraged a breakthrough process.
Speeding Up

Vaccine development is typically slow and high risk. The project’s goal is to cut out the slow part, the people said. Operation Warp Speed will use government resources to quickly test the world’s most promising experimental vaccines in animals, then launch coordinated human clinical trials to winnow down the candidates.
The group is discussing which Americans might be vaccinated first, as the medicines would likely roll off production lines in batches, one of the people said. The project would be funded from money already available to the government and won’t require new authority from Congress, one of the people said.

There are at least 70 different coronavirus vaccines in development by drugmakers and research groups, according to the World Health Organization. But drugmakers have not coordinated their efforts to the extent they could through the Warp Speed project, one of the people said.
Under the effort, the Defense Department would make its animal research resources available for pre-clinical work on vaccines.

The group is also discussing the use of what’s known as a master protocol to test the vaccines. Instead of multiple clinical trials run by each drugmaker, competing for patients and resources, the government would organize one large trial to test several vaccines at once and advance the most promising ones.
Oxford Vaccine

The Trump administration isn’t alone in trying to fast-track a vaccine. One of the world’s most promising vaccine candidates has been developed by a team at Oxford University in London. Last month, scientists at the U.S. National Institutes of Health innoculated six rhesus macaques with the Oxford vaccine and then exposed them to the coronavirus, the New York Times reported.

All six were healthy more than four weeks later, according to the Times. The researchers are currently testing their vaccine in 1,000 patients and plan to expand to stage two and three clinical trials next month involving about 5,000 more people.

The Oxford group told the Times they could have several million doses of their vaccine produced and approved by regulators as early as September.

In the U.S., the Bill & Melinda Gates Foundation has meanwhile shifted much of its research effort to the coronavirus virus.

One of the people familiar with Operation Warp Speed drew a distinction with the Oxford group, describing the U.S. effort as broader in scope. It’s unclear which vaccine candidates would be part of Operation Warp Speed, or whether it would include the Oxford vaccine.

More than 1 million cases of coronavirus have been confirmed in the U.S., and at least 58,000 people have died from the illness it causes in the last two months. Widespread social-distancing measures have helped slow the spread, but at the cost of millions of jobs and losses to the economy that experts fear will take years to recover.

Along with wider diagnostic testing for the virus and an effective therapeutic drug, a vaccine is one of the key tools for reducing long-term risk from the virus. Testing can help contain an outbreak in its early stages, or after it’s been curbed enough to manage. A therapy can help those who get sick, reducing the risk of death and the burden on hospitals.

Gilead Sciences Inc. announced Wednesday that in a trial conducted by Fauci’s agency, the U.S. National Institute of Allergy and Infectious Diseases, its experimental coronavirus therapy remdesivir helped patients recover faster than under standard care. More here from Bloomberg